Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 39 - Medicinal preparations containing antigens or antibodies
Patents for A61K 39 - Medicinal preparations containing antigens or antibodies (182,248)
11/2005
11/17/2005CA2564769A1 Cellular permissivity factor for viruses, and uses thereof
11/17/2005CA2563516A1 Monoclonal antibody sc104 and derivative thereof specifically binding to a sialyltetraosyl carbohydrate as a potential anti-tumor therapeutic agent
11/17/2005CA2563080A1 Monoclonal antibodies to hepatocyte growth factor
11/17/2005CA2560865A1 Cancer associated antigens
11/17/2005CA2559371A1 Influenza virus vaccines
11/16/2005EP1595959A1 Method for enhancing efficacy of preparation of monoclonal antibody
11/16/2005EP1595951A1 Diagnosis and treatment of diseases using peptides which are bound by specific anti-anti-t-cell receptor vbeta antibodies
11/16/2005EP1595890A2 Synthetic peptide inhibitors of HIV transmission
11/16/2005EP1595573A2 Stent comprising manipulators of nitrosative stress to reduce restenosis
11/16/2005EP1595548A2 Anti-neovasculature preparations for treating cancer
11/16/2005EP1595546A1 Remedy for cancer
11/16/2005EP1595145A2 Methods for the treatment of renal cell carcinoma
11/16/2005EP1595142A2 Method for evaluating the efficacy of certain cancer treatments
11/16/2005EP1594989A2 Methods for the early diagnosis of ovarian cancer
11/16/2005EP1594969A2 Active immunization to generate antibodies to soluble a-beta
11/16/2005EP1594899A1 Idiotypic vaccine
11/16/2005EP1594897A2 Use of il-6 antagonists in combination with steroids to enhance apoptosis
11/16/2005EP1594893A2 Therapeutic targets in cancer
11/16/2005EP1594892A2 Nucleic acid and corresponding protein named 158p1d7 useful in the treatment and detection of bladder and other cancers
11/16/2005EP1594888A2 Tolerance-induced targeted antibody production
11/16/2005EP1594561A2 Yersinia species compositions
11/16/2005EP1594560A2 Compositions, methods and kits for enhancing the immunogenicity of a bacterial vaccine vector
11/16/2005EP1594552A2 Topical delivery of cosmetic agents
11/16/2005EP1594548A1 Anthracycline-antibody conjugates
11/16/2005EP1594543A2 Immunogene adherence and method of making and using the same
11/16/2005EP1594542A2 Anti-cd70 antibody-drug conjugates and their use for the treatment of cancer and immune disorders
11/16/2005EP1594541A2 Method and compositions for the treatment of meconium aspiration syndrome
11/16/2005EP1594540A1 New pharmaceutical compositions based on anticholinergics and anti-tnf antibodies
11/16/2005EP1594539A2 Compositions for modulating immune cell activity and methods for detection thereof
11/16/2005EP1594538A2 Composition to be administered to a living being and method for marking agents
11/16/2005EP1594537A1 Vaccination or immunization using a prime-boost regimen against brsv, bhv-1, bvdv, bpi-3
11/16/2005EP1594536A2 Adjuvanted influenza vaccine
11/16/2005EP1594535A2 Immunogenic acute phase protein-antigenic molecule complexes and fusion proteins
11/16/2005EP1594534A2 Immunogenic acute phase protein-antigenic molecule complexes and fusion proteins
11/16/2005EP1594533A2 Antibody vaccine conjugates and uses therefor
11/16/2005EP1594524A2 Use of tryptanthrin compounds for immune potentiation
11/16/2005EP1594466A1 Virosome-like-particles
11/16/2005EP1594444A2 Methods and compositions for the treatment and prevention of staphylococcus and other bacterial infections
11/16/2005EP1594443A2 Immunogenic cd19 ligand-antigenic molecule complexes and fusion proteins
11/16/2005EP1594441A2 Method for treating pain by administering a nerve growth factor antagonist and an nsaid and composition containing the same
11/16/2005EP1594439A2 REGULATION OF FOOD INTAKE AND GLUCOSE PRODUCTION BY MODULATION OF LONG-CHAIN FATTY ACYL-CoA LEVELS IN THE HYPOTHALAMUS
11/16/2005EP1594437A2 Immunogenic cd91 ligand-antigenic molecule complexes and fusion proteins
11/16/2005EP1594436A2 Polymer conjugates of mutated neublastin
11/16/2005EP1594435A2 Inhibition of hiv-1 replication by disruption of the processing of the viral capsid-spacer peptide 1 protein
11/16/2005EP1594434A2 Parenteral formulations of peptides for the treatment of systemic lupus erythematosus
11/16/2005EP1594432A2 Short immunomodulatory oligonucleotides
11/16/2005EP1506223B1 Fusion protein of hiv regulatory/accessory proteins
11/16/2005EP1307466B1 Immunological adjuvant compounds
11/16/2005EP1216053B1 Influenza vaccine
11/16/2005EP1206550B1 Proteins derived from white spot syndrome virus and uses thereof
11/16/2005EP1100515B1 EX VIVO TREATMENT OF ALLOGENEIC AND XENOGENEIC T-CELLS WITH gp39 ANTAGONISTS
11/16/2005EP1068328B1 Treatment and diagnosis of staphylococcal infections
11/16/2005EP0970211B1 Variants of ciliary neurotrophic factor with enhanced receptor selectivity and method for their selection
11/16/2005EP0741745B1 Hepatitis b vaccine
11/16/2005CN1697659A Cancer therapy using whole glucan particles and antibodies
11/16/2005CN1697647A Liquor and method for restraining ache, inflammation and cartilage degradation
11/16/2005CN1697644A Materials and methods for preventing and treating microbe-mediated epithelial disorders
11/16/2005CN1696293A Gene recombined chemotaxis antigen vaccine
11/16/2005CN1695737A Freezedrying type vaccine of AIDS recombined poxvirus with Ankara gene stock carrier, and preparation method
11/16/2005CN1695736A Vaccine for virus of encephalitis B and preparation method
11/16/2005CN1227360C Tumor-associated antigen derivatives from MAGE family, and nucleic acid sequence encoding them
11/16/2005CN1227265C Antibodies to CCR5
11/16/2005CN1227264C Immunogenic peptides derived from MAGE and use thereof
11/16/2005CN1227263C Peptide diagnostic and therapeutic agent for autoimmune diseases
11/16/2005CN1227035C Conjugates and method for production thereof, and their use for transporting molecules via biological membranes
11/16/2005CN1227033C Method of treating cancer with anti-neurotrophin agents
11/16/2005CN1227032C Vaccines with an LTB adjuvant
11/16/2005CN1227031C Application of varicella-zoster-virus for preparing varicella preventing medicine
11/16/2005CN1227030C Adjuvant composition comprising saponin and an immunostimulatory oligonucleotide
11/15/2005US6965018 Antibodies directed to B7-related polypeptide, BSL-2
11/15/2005US6965017 Melanoma antigens and their use in diagnostic and therapeutic methods
11/15/2005US6965016 Antagonist for use in the prevention of fertility in humans and animals
11/15/2005US6964853 Smad6 and uses thereof
11/15/2005US6964852 Antigenic structural peptide, antigenic and immunogenic compounds, and uses for detecting, preventing and treating an HCV infection
11/15/2005US6964851 Peptide for use in the treatment of hypertension, cancer, ischemia, trauma, infection inflammation, fever, heart and nervous system disorders
11/15/2005US6964845 Thermostable phage lambda operator mutants for regulating gene expression
11/15/2005US6964843 Methods and reagents for the detection of antibodies to adenovirus
11/15/2005US6964770 Recombinant plasmid and a method of controlling the effects of Yersinia pestis
11/15/2005US6964769 Molecular antigen array
11/15/2005US6964767 Polypeptides; detecting infections using antibodies
11/15/2005US6964762 Composition and method for stimulating immune response to pathogen using complex adenoviral vector
11/15/2005CA2279204C Use of microparticles with adsorbed antigen to stimulate immune responses
11/15/2005CA2182315C Expression of heterologous proteins in attenuated bacteria using the htra-promoters
11/15/2005CA2155533C Process for growing porcine reproductive and respiratory syndrome virus and its use in vaccines
11/14/2005CA2810292A1 Ligand for g-protein coupled receptor fprl2 and uses thereof
11/14/2005CA2504920A1 Ligand for g-protein coupled receptor fprl2 and uses thereof
11/14/2005CA2467329A1 Inner core lps epitopes and uses thereof
11/10/2005WO2005106493A1 Diagnostics and therapeutics for diseases associated with g protein-coupled apelin receptor (apj)
11/10/2005WO2005106476A2 Method for diagnosing infectious diseases
11/10/2005WO2005106473A1 Method of screening therapeutic agent for neurodegenerative disease
11/10/2005WO2005106039A1 Ibc-1 (invasive breast cancer-1), a putative oncogene amplified in breast cancer
11/10/2005WO2005106021A1 Diagnostics and therapeutics for diseases associated with dipeptidyl-peptidase 8 (dpp8)
11/10/2005WO2005106016A1 METHOD OF DETECTING Th1 CELL
11/10/2005WO2005106009A2 Lactoferrin cleavage of neisserial proteins
11/10/2005WO2005106002A2 Polyvalent viral vectors and a system for production thereof
11/10/2005WO2005105998A1 HUMAN ANTIAMYLOID β PEPTIDE ANTIBODY AND ANTIBODY FRAGMENT THEREOF
11/10/2005WO2005105987A1 Diagnostics and therapeutics for diseases associated with casein kinase 1, delta, isoform 2 (csnk1d iso 2)
11/10/2005WO2005105849A1 Compositions and methods for treating proliferative disorders such as nk-type ldgl
11/10/2005WO2005105848A1 Compositions and methods for enhancing nk cell activity
11/10/2005WO2005105845A2 Phep, an amino acid permease of staphylococcus aureus
1 ... 1013 1014 1015 1016 1017 1018 1019 1020 1021 1022 1023 1024 1025 1026 1027 1028 1029 1030 1031 1032 1033 ... 1823